Raymond James & Associates decreased its holdings in Evoqua Water Technologies Corp. (NYSE: AQUA) during the third quarter, as stated in the most recent report that the company filed with the Securities and Exchange Commission (SEC) (SEC). Following the completion of the quarter in which 15,362 shares of the company’s stock were sold, the institutional investor’s portfolio currently consists of 72,783 shares. Raymond James & Associates had approximately 0.06% of the shares in Evoqua Water Technologies at the end of the most recent fiscal quarter, with a value of $2,407,000.
A sizeable number of additional institutional investors and hedge funds have decided to sell their AQUA holdings. US Bancorp DE increased its stake in Evoqua Water Technologies by 73.5% during the first three months of the current fiscal year.
After purchasing an additional 4,573 shares during the most recent quarter, US Bancorp DE now has a total of 10,795 shares, which are worth a combined total of $507,000. These shares were acquired during the most recent quarter.
During the first three months of the year, Cambridge Investment Research Advisors Inc.
Made a total investment in Evoqua Water Technologies amounting to approximately 316 thousand dollars.
In the first three months of 2018, Cetera Advisor Networks LLC made a new holding investment in Evoqua Water Technologies for 434,000 dollars.
During the first three months of 2018, the Bank of Montreal Canada spent nearly 222 thousand Canadian dollars to acquire a new position at Evoqua Water Technologies.
Last but not least, during the first three months of this year, MetLife Investment Management LLC increased the amount of equity it held in Evoqua Water Technologies by 54.6%.
After purchasing an additional 21,841 shares during the period, MetLife Investment Management LLC now has a total of 61,851 shares worth a combined total of $2,906,000. This brings the total number of shares the company currently holds to 61,851.
Institutional investors and hedge funds currently own 93.46% of the company’s shares between them.
The first day of trading for AQUA was Monday, and the opening price was $41.03. Compared to the amount of equity, the debt is 1.22 times as high, the quick ratio is 1.24 times as high, and the current ratio is 1.72 times as high. Over the last 52 weeks, the price of Evoqua Water Technologies Corp. has ranged from a low of $30.44 to a high of $48.05 at various points. The moving average price for the company over the past 50 days is currently sitting at $41.73, while the moving average price for the past 200 days is currently at $38.25. The price-to-earnings ratio of the company is 70.74, which contributes to the total market value of the company, which is $5 billion.
Its beta value is 1.72, and its price-to-earnings-to-growth ratio comes in at 3.39.
The most recent earnings report for Evoqua Water Technologies, traded on the New York Stock Exchange under the AQUA ticker, was released on November 15. The company announced earnings per share for the quarter of $0.42, which was $0.13 higher than the consensus estimate among analysts, who had predicted earnings per share of $0.29.
Evoqua Water Technologies reported a return on equity of 16.40%, while the company’s net margin came in at 4.16%. The company brought in $504.76 million in revenue for the quarter, significantly higher than the $463.90 million market watchers predicted it would bring in.
It is anticipated by those who follow the market that Evoqua Water Technologies Corp. will generate earnings of $0.81 per share this year.
Several industry professionals actively engaged in equity research have recently penned reports on the stock in question that are being questioned. The price target Stifel Nicolaus has set for Evoqua Water Technologies shares has increased from $43.00 to $50.00 due to research that was made public on November 16. Oppenheimer lowered their recommendation for the stock of Evoqua Water Technologies from “outperform” to “market perform,” and they set their price objective for the company at $45.00.
A report was made public on November 16, which was a Wednesday. Citigroup disclosed on November 16 that it had increased its price objective for Evoqua Water Technologies shares from $37.00 to $45.00. This information was included in a research report made available to the public on November 16.
In a research report published on November 16, Goldman Sachs Group reaffirmed their “buy” recommendation on the shares of Evoqua Water Technologies, moving them up from their previous “hold” rating of the stock. The report was based on research that was conducted before November 16. The price objective that the Royal Bank of Canada has set for Evoqua Water Technologies shares has grown from $44.00 to $51.00, as stated in a research report that was issued on Wednesday, November 16. Only one of the analysts has recommended that shareholders maintain their current holdings in the company, while the other four have given it a buy rating.
According to information provided by Bloomberg, the current average rating for Evoqua Water Technologies is “Moderate Buy,” and the consensus price objective for the company is $47.50.
The municipal, commercial, and industrial water treatment markets are some of the ones that Evoqua Water Technologies Corp. serves in the United States and internationally. The company offers emergency water supply solutions in addition to contract services, mobile water supply solutions, and solutions for supplying water in an emergency.
Applied Product Technologies and Integrated Solutions and Services are the names of the company’s respective divisions. The company is organized into these two sections.
You are interested in discovering whether or not other hedge funds are monitoring AQUA, and you want to know if this is the case.
By going to HoldingsChannel.com, you can investigate the most recent 13F filings and insider transactions for Evoqua Water Technologies Corp. (NYSE: AQUA).
Source: news.google.com
